RT Journal Article
SR Electronic
T1 One size does not fit all. Genomics differentiates among binge-eating disorder, bulimia nervosa, and anorexia nervosa
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.03.24.20042648
DO 10.1101/2020.03.24.20042648
A1 Christopher Hübel
A1 Mohamed Abdulkadir
A1 Moritz Herle
A1 Ruth J.F. Loos
A1 Gerome Breen
A1 Cynthia M. Bulik
A1 Nadia Micali
YR 2021
UL http://medrxiv.org/content/early/2021/01/04/2020.03.24.20042648.abstract
AB Objective Genome-wide association studies have identified multiple genomic regions associated with anorexia nervosa. Relatively few or no genome-wide studies of other eating disorders, such as bulimia nervosa and binge-eating disorder, have been performed, despite their substantial heritability. Exploratively, we aimed to identify traits that are genetically associated with binge-type eating disorders.Method We calculated genome-wide polygenic scores for 269 trait and disease outcomes using PRSice v2.2 and their association with anorexia nervosa, bulimia nervosa, and binge-eating disorder in up to 640 cases and 17,050 controls from the UK Biobank. Significant associations were tested for replication in the Avon Longitudinal Study of Parents and Children (up to 217 cases and 3018 controls).Results Individuals with binge-type eating disorders had higher polygenic scores than controls for other psychiatric disorders, including depression, schizophrenia, and attention deficit hyperactivity disorder, and higher polygenic scores for body mass index.Discussion Our findings replicate some of the known comorbidities of eating disorders on a genomic level and motivate a deeper investigation of shared and unique genomic factors across the three primary eating disorders.Competing Interest StatementDr. Breen has received grant funding from and served as a consultant to Eli Lilly, has received honoraria from Illumina and has served on advisory boards for Otsuka. Dr. Bulik is a grant recipient from and has served on advisory boards for Shire and is a consultant for Idorsia. She receives royalties from Pearson. All other authors have indicated they have no conflicts of interest to disclose.Funding StatementThis study represents independent research part funded by the UK National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and Kings College London. The views expressed are those of the author(s) and not necessarily those of the UK NHS, the NIHR or the Department of Health. High performance computing facilities were funded with capital equipment grants from the GSTT Charity (TR130505) and Maudsley Charity (980). This work was supported by the UK Medical Research Council and the Medical Research Foundation (ref: MR/R004803/1). The UK Medical Research Council and Wellcome (Grant ref: 102215/2/13/2 and 217065/Z/19/Z) and the University of Bristol provide core support for ALSPAC. A comprehensive list of grants funding is available on the ALSPAC website (http://www.bristol.ac.uk/alspac/external/documents/grant-acknowledgements.pdf); This research was specifically funded by the NIHR (CS/01/2008/014), the NIH (MH087786-01). GWAS data was generated by Sample Logistics and Genotyping Facilities at Wellcome Sanger Institute and LabCorp (Laboratory Corporation of America) using support from 23andMe. NM and CB acknowledge funding from the National Institute of Mental Health (R21 MH115397). CB acknowledges funding from the Swedish Research Council (VR Dnr: 538-2013-8864), the National Institute of Mental Health (R21MH115397; R01 MH109528; R01MH120170; R01MH119084; R01MH120170), and Lundbeckfonden. MH is supported by fellowship from the Medical Research Council UK (MR/T027843/1). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders were not involved in the design or conduct of the study; collection, management, analysis, or interpretation of the data; or preparation, review, or approval of the manuscript.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThis study is based on data from the UK Biobank. Researchers can apply for the data via the following website: https://www.ukbiobank.ac.uk/. This study is based on data from the ALSPAC study (http://www.bristol.ac.uk/alspac/). Interested researchers can apply for data access with the University of Bristol, UK. Analysis scripts can be requested from the authors.